National Registry of DiseasesAct 2007

National Registry of Diseases Act 2007 2020 REVISED EDITION This revised edition incorporates all amendments up to and including 1 December 2021 and comes into operation on 31 December 2021 An Act to establish the National Registry of Diseases and to provide for the compilation of information on the incidence of certain diseases for use as a basis for the direction of programmes for disease prevention and control, and for purposes connected therewith. [1 August 2009] PART 1 PRELIMINARY Short title 1. This Act is the National Registry of Diseases Act 2007. Interpretation 2. In this Act, unless the context otherwise requires — “agent of the Registry” means any public officer or employee of any statutory body who is appointed by the Director‑General under section 3(3) to be an agent of the Registry; [Act 11 of 2023 wef 01/05/2023] “anonymised”, when used to describe information pertaining to an individual, means that the identity of that individual has been concealed or protected, whether by presenting the information in a statistical form or otherwise, such that it cannot be readily discovered or ascertained from that information; “approved conveyance” has the meaning given by section 2(1) of the Healthcare Services Act 2020; [Act 19 of 2025 wef 05/12/2025] “approved permanent premises” has the meaning given by section 2(1) of the Healthcare Services Act 2020; [Act 19 of 2025 wef 05/12/2025] “authorised Registry officer” means any Registry officer who is duly authorised by the Registrar in writing to carry out any particular function or to exercise any particular power under this Act; [Deleted by Act 11 of 2023 wef 01/05/2023] “Director‑General” means the Director‑General of Health; [Act 11 of 2023 wef 01/05/2023] “disclose”, in relation to any information held by the Registry, includes to grant to any person access to that information; “disease” means any physical or mental ailment, disorder, defect or morbid condition (whether of sudden onset or gradual development), or the recurrence of that ailment, disorder, defect or morbid condition; “healthcare institution” means — (a) any approved permanent premises at which, or any approved conveyance in or from which, the holder of a licence granted under the Healthcare Services Act 2020 is approved to provide any one or more of the following licensable healthcare services: (i) an acute hospital service; (ii) an ambulatory surgical centre service; (iii) a clinical laboratory service; (iv) a community hospital service; (v) a nuclear medicine service; (vi) an outpatient dental service; (vii) an outpatient medical service; (viii) an outpatient renal dialysis service; (ix) a radiological service; (x) any other licensable healthcare service that may be prescribed; or (b) any facility, premises or conveyance declared by the Minister, by order in the Gazette, to be a healthcare institution for the purposes of this Act; [Act 19 of 2025 wef 05/12/2025] “individually-identifiable”, when used to describe information pertaining to an individual, means that the identity of that individual can be readily discovered or ascertained from that information; “investigation officer” means any public officer who is appointed under section 13 to be an investigation officer for the purposes of this Act; “licensable healthcare service” has the meaning given by section 3(1) of the Healthcare Services Act 2020; [Act 19 of 2025 wef 05/12/2025] “manager”, in relation to a healthcare institution, means the individual having the management or control of the healthcare institution; [Act 3 of 2020 wef 03/01/2022] “medical practitioner” means a medical practitioner registered under the Medical Registration Act 1997 and who holds a valid practising certificate; “register” means a register kept and maintained by the Registrar under section 5; “Registrar” means the person appointed by the Director‑General under section 3 to be the Registrar of the Registry and includes a Deputy Registrar and an Assistant Registrar; [Act 11 of 2023 wef 01/05/2023] “Registry” means the National Registry of Diseases established under section 4; “Registry officer” means any person who is appointed by the Director‑General under section 3 to be an officer of the Registry; [Act 11 of 2023 wef 01/05/2023] “regulations” means regulations made under section 23; “reportable disease” means a disease that is specified in the Schedule; “requisite consent”, for the purposes of section 11 or 12, means — (a) the consent, given in the prescribed form and manner, of the person whose individually‑identifiable information is to be disclosed under that section; or (b) where the person mentioned in paragraph (a) is unable to give his or her own consent due to age, infirmity of mind or body or any other cause, the consent, given in the prescribed form and manner, of such other person who is authorised by the regulations to give such consent for and on his or her behalf.